Health Sobi Acquires Arthrosi Therapeutics for $950 Million Sobi, a prominent biopharmaceutical company, is set to acquire Arthrosi Therapeutics, a biotechnology firm focused on gout treatments, for an initial payment of $950... Editorial3 days ago